DNA Rearrangements Impairing BK Virus Productive Infection in Urinary Tract Tumors  by MONINI, PAOLO et al.
VIROLOGY 214, 273–279 (1995)
SHORT COMMUNICATION
DNA Rearrangements Impairing BK Virus Productive Infection in Urinary Tract Tumors
PAOLO MONINI,1 ANTONELLA ROTOLA, DARIO DI LUCA, LAURA DE LELLIS, ELISABETTA CHIARI,
ALFREDO CORALLINI, and ENZO CASSAI
Institute of Microbiology, University of Ferrara, 44100 Ferrara, Italy
Received January 17, 1995; accepted October 3, 1995
Eighty-nine tissue specimens from the urinary tract and prostate were analyzed for the presence and physical state of
BK virus (BKV) DNA. Large T antigen gene sequences were amplified by PCR from prostate, kidney, ureter, and bladder
with prevalences ranging from 50 to 83%. Sequence analysis of PCR products from the high variable BKV regulatory region
showed that these tissues contained a new BKV strain (URO1). URO1 presents a duplication of part of the 68- and 39-bp
elements of the viral enhancer, and a 68-bp deletion spanning part of the 39- and 63-bp enhancer elements. Six neoplastic
specimens (11.5%), but none of the control tissues, contained viral DNA in amounts detectable by Southern blot hybridization
(P  0.05). The tumors positive by Southern blot hybridization harbored rearranged and/or integrated DNA sequences
whose size was apparently incompatible with assembly into a viral particle. A full-length, macroscopically intact BKV early
region was amplified from these tumors by PCR. The restriction pattern of the rearranged sequences was simple, suggesting
that tumors were clonal and that DNA rearrangement occurred at an early stage of neoplastic initiation or progression.
q 1995 Academic Press, Inc.
BK virus (BKV) is a human papovavirus infecting a large sediment and bordering the ureter lumen (7, 13). The
main site of viral persistence in immunocompetent indi-portion of the human population in childhood. Primary
infection is usually not apparent and is only occasionally viduals is the kidney, where BKV DNA is present in few
cell foci at high copy numbers (15). Urinary tract tissuesassociated with upper respiratory or urinary tract disease
(for a review see reference 29). Like the closely related are therefore the principal target for both productive and
latent infection. Despite this, the search for a possibleSimian virus 40 (SV40), BKV transforms hamster, rat,
mouse, rabbit, monkey, and human cells in vitro and is role of BKV in urinary tract neoplasms has been fragmen-
tary. In earlier studies, some cell lines and a few tumorsoncogenic in rodents, causing tumors in 73 to 88% of
hamsters inoculated intravenously or intracerebrally. BKV were analyzed for the presence of BKV DNA and poly-
cooperates with activated oncogenes in cell transforma- omavirus large T expression with negative results (14,
tion and tumor induction, and it may therefore provide 25). However, those studies were conducted with rela-
one of the several functions involved in oncogenesis (9, tively low-sensitivity DNA hybridization and immunofluo-
and references therein). BKV DNA is often present in rescence techniques. In the present study, 89 prostate
human cerebral tumors, tumors of the pancreatic islets, and urinary tract specimens were analyzed by PCR and
Kaposi’s sarcomas, and other tumors (8, 10, 19), and a Southern blot hybridization for the presence and physical
viral strain (BKV-IR) containing a putative transposable state of BKV DNA.
element in the regulatory region of the viral genome has Tissue biopsies were collected and extracted at differ-
been rescued from several neoplasms (19, 21). ent times (in a period of 2 years). DNA extraction was
In immunocompetent individuals, BKV persists in a la- performed in a room that was never in contact with viral
tent form in the kidney, tonsils, brain, and other organs DNA. All PCR reactions were set in a second room which
and tissues. Viral infection is reactivated in individuals was never in contact with DNA, either of viral or human
with various degrees of immunological deficit such as origin. Template and control DNA were added in a third
pregnant women, transplant recipients, and AIDS pa- room, making use of a cart covered with paper sheets
tients. As BKV undergoes vegetative replication, viral par- that were discarded after each experiment. Negative-
ticles are secreted in the urine, and intracellular virions control PCR reactions, performed without template DNA
are accumulated within the epithelial cells of the urine and processed with the specimens, were negative. DNAs
purified from the specimens (Table 1) were analyzed by
PCR with primers amplifying a 181-bp DNA sequence1 To whom correspondence and reprint requests should be ad-
dressed. contained within BKV large T antigen gene (3) (PYV.for
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TABLE 1 gels and hybridized under high stringency conditions (Td
057) with a specific 32P-end-labeled oligonucleotidePrevalence of BKV Large T by PCR in Urinary Tract
probe (3) (Fig. 1B). Fifty-two of eighty-nine specimens
Hystotype Prevalence (58.4%) yielded signals of the expected size. Samples
showing faint signals (for example, samples 13, 23, and
Bladder 24 of Fig. 1B) were considered positive only if they were
Infiltrant Urothelial Carcinomas 5/8
amplified in multiple trials. The range of signal intensityPapillar Urothelial Carcinomas 6/9
and the prevalence of BKV large T antigen DNA se-Urothelial Carcinomas 4/9
Total Neoplastic 15/26 (58%) quences in neoplastic and nonneoplastic specimen were
Nonneoplastic tissues 5/10 (50%) comparable (Fisher’s test; not significant). Under the em-
Total 20/36 (56%) ployed conditions it was always possible to detect 1
Prostate
target in about 2000 cells by ethidium bromide stainingInfiltrant Adenocarcinomas 4/7 (57%)
(data not shown).Hyperplasias 11/19 (58%)
Total 15/26 (58%) DNA sequences from the BKV regulatory region were
Kidney amplified from nine positive tissue specimens, and PCR
Infiltrant Adenocarcinomas 9/10 products were sequenced by the dideoxy technique.
Urothelial Carcinomas 1/1
These specimens consisted of three PCR-positive pros-Infiltrant Carcinomas of 0/1
tate hyperplasias, three PCR-positive neoplastic lesionsCollecting Tubules
Cystic Papillar Adenocarcinomas 0/1 (two kidney adenocarcinomas and one ureter carci-
Cystic Papillar Carcinomas 0/1 noma), and three bladder urothelial carcinomas con-
Nefroblastomas 0/1 taining BKV DNA in amounts detectable by Southern blot
Total Neoplastic 10/15 (60%)
hybridization (see below). BKV regulatory region was am-Nonneoplastic tissues 5/6 (83%)
plified by nested PCR with primers BKRRLT-1/BK-RRLT6Total 15/21 (71%)
Ureter and BRP-1/BRP-2 (20) (Fig. 1A). Negative-control PCR re-
Papillar Urothelial Carcinomas 2/4 actions performed without DNA template were negative.
Nonneoplastic tissues 0/1 PCR products were gel purified by absorption on a glass
Total 2/5 (40%)
milk matrix (MERmaid kit, BIO 101, Inc., Vista, CA) andUrethra
sequenced with the ‘‘fmol DNA Sequencing System’’ (Pro-Nonneoplastic tissues 0/1
Total 52/89 (58.4%) mega, Madison, WI). PCR products from all nine speci-
mens had the same structure, and one Southern blot-
Note. Three bladder and two kidney specimens were biopsies from positive urothelial bladder carcinoma presented twonormal tissue adjacent to neoplastic lesions.
point mutations (Fig. 2). The regulatory region amplified
from these specimens had a 61-bp duplication spanning
part of the 68- and 39-bp enhancer elements present inand PYV.rev, Fig. 1A). The conditions for PCR reactions
the putative archetypal BKV (29). In addition, a 68-bpwere 957 for 4 min followed by 40 cycles each performed
deletion was present within the 39- and 63-bp enhancerat 947 for 1 min, 527 for 30 sec, and 727 for 1 min, with
elements (Fig. 2). DNA rearrangements in the BKV regula-0.15 mM primers and 1.5 mM MgCl2 . Aliquots of the reac-
tions were electrophorised through 4% (w/v) agarose tory region have been described before (20, 29). How-
FIG. 1. (A) Oligonucleotide primers and probe used in the study. The diagram shows BKV early region. Filled boxes, sequences coding for BKV
large T antigen; thin lines, BKV regulatory region and untranslated sequences. Large T intron is shown. Unpublished oligonucleotides are: GGC
GCA GAA CCA TGG CCT TT, BK-RRLT1; GAA AGA CTT CCA GGG GAC CCA GA, BK-RRLT-4; AGA TAT ATT GAC AAA CAG GGA CAA TT, BK-RRLT-
5; AAT AGG GAT TTC CCC AAA TA, BK-RRLT-6. (B) Southern blot analysis of PCR products amplified with primers PYV.for and PYV.rev. Amplified
DNA fragments from the indicated specimens were hybridized to a 32P-labeled oligonucleotide probe internal to the amplified products. The size
of PCR products (181 bp) was estimated by comparison with a 123-bp DNA ladder. A positive control reaction, performed with prototype BKV DNA
(Gardner strain) is shown. NC, negative control PCR reaction lacking DNA template. Samples are: 15, prostate carcinoma; 23, 24, prostate hyperplasia;
12, 13, 14, 18, 22, kidney carcinoma; 17, 21, bladder carcinoma; Samples 18A and 17A consisted of nonneoplastic tissue adjacent to neoplastic
lesions 18 and 17.
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FIG. 2. Nucleotide sequence of PCR products amplified from the regulatory region of BKV with primers BRP-1 and BRP-2. The DNA sequence of
the proposed archetypal BKV regulatory region is compared to the sequence found in viral strain URO1. The 68- and 63-bp elements surrounding
the 39-bp element of viral enhancer are boxed in the archetypal BKV sequence. The two nucleotides indicated by arrows were mutated (C r T) in
a bladder carcinoma containing integrated BKV DNA. Duplicated sequences are underlined by an arrow; deletions are indicated with dashed lines.
Nucleotide numeration of the archetypal BKV regulatory region is as in Negrini et al. (20). GenBank Accession Number: Bankie11437 U33549.
ever, the structure and boundaries of the rearrangements tions or of episomal, rearranged variants (Fig. 3A). All
specimens showed a simple restriction pattern, sug-found in these specimens are different from that of all
known BKV strains and were not matched by any of the gesting that tumors were clonal. In all instances, the size
of the aberrant bands was significantly larger than theBKV isolates present in the GenBank. This arrangement,
therefore, identifies a novel BKV strain (URO1) with a BKV prototype genome.
To ascertain whether BKV early promoter and T anti-high prevalence in the urinary tract of Italian patients.
All the specimens were analyzed by Southern blot hy- gen DNA sequences were intact in the rearranged se-
quences, the specimens were analyzed by nested PCRbridization for homology to a BKV genomic probe under
high stringency conditions (hybridization at Tm 0207; with primers able to amplify the entire viral early region.
As these primers are expected to amplify sequences ofwashes at Tm) (Fig. 3A). Six PCR-positive neoplastic spec-
imens (three papillar and one infiltrant urothelial carcino- about 2.7–2.9 kb (depending on the viral strain), cellular
DNAs were ligated in order to repair DNA nicks andmas of the bladder, one prostate adenocarcinoma, and
one adenocarcinoma of the kidney) contained viral se- increase the fraction of template suitable for PCR amplifi-
cation. This analysis was performed with four Southernquences in amounts detectable by this technique, while
none of the nonneoplastic specimens was positive. A positive specimens (the DNA of which was still available
for further processing) and three PCR-positive samples.tissue biopsy from normal tissue adjacent to a Southern
blot-positive bladder carcinoma was positive only by PCR A first PCR reaction was performed with 0.5 mM primers
(BK-RRLT-1 and BK-RRLT-4, Fig. 1A) and 1.5 mM MgCl2(samples 17 and 17A in Fig. 1B). Statistical analysis re-
vealed that the different viral DNA load in neoplastic and at 957 for 1 min, 607 for 1 min, 727 for 2 min, for a total of
40 cycles. A second (nested) PCR round was performednonneoplastic tissues was significant (Fisher’s test; P 
0.035). Four of the Southern blot-positive tumors con- under similar conditions with primers BK-RRLT-5 and
BRP-2 (Fig. 1A). The amplified products were then hybrid-tained less than 0.1 copy per cell; two bladder carcino-
mas contained about 1 and 50 copies of viral DNA per ized to a BKV genomic probe either untreated or after
HindIII digestion. All specimens yielded bands of thecell, respectively. Southern blot hybridization sensitivity
was about 0.05 viral genomes per diploid genome (data expected size, while reactions performed with HeLa cells
or the cervical cell line 612 (16), as well as several nega-not shown). These results contrast with the study by
McCance and co-workers, which detected BKV DNA in tive control-reactions lacking the template DNA, were
negative (Figs. 3B and 3C). These data showed that full-normal kidney parenchyma using Southern blot hybrid-
ization (15). It should be noted, however, that latent BKV length large T antigen coding sequences were retained
in these tumors.DNA is present only within few kidney parenchyma cell
foci (15) and that those studies were done by analyzing A detailed analysis of viral DNA sequences was possi-
ble in two bladder carcinomas containing, respectively,several kidney sections from organs of autoptic origin.
In contrast, we analyzed small biopsies, and the likeli- 1 and 50 copies of BKV (URO1) DNA per cell. One carci-
noma (specimen 17) yielded a hybridization signal mi-hood of detecting latent BKV DNA was, therefore, propor-
tionally lower. grating with the bulk of cellular DNA in two-dimensional
gel electrophoresis (17, 24). Cleavage with endonucle-After cleavage with EcoRI endonuclease, cutting once
in the BKV prototype DNA, all Southern blot-positive tu- ases which do not cut BKV prototype genome produced
hybridization bands of variable size, showing that themors produced bands with a different molecular weight
than the full-length BKV genome, suggestive of integra- viral genome was integrated at a single site in the cell
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FIG. 3. (A) Southern blot analysis of EcoRI-digested DNA from six PCR-positive neoplastic specimens. Molecular weight markers are HindIII
phage lambda DNA fragments. Lanes C1 and C3, 5 and 0.5 equivalents per cell of BKV circular DNA; lane C2, 2 equivalents of BKV-linearized DNA
(Gardner strain). The picture shows positive specimens individually photographed from autoradiograms of different Southern blot hybridization
experiments. The amount of BKV DNA present in the specimens was estimated by including in each Southern blot experiment known amounts of
purified BKV DNA (0.1 to 100 genome equivalents per cell). Samples 27 and 17 contained 50 and 1 equivalents per cell, respectively; viral DNA
content in the other specimens ranged from 0.5 to less than 0.1 copies per diploid genome. The length of autoradiographic exposure of the individual
blots varied from 12 hr to 3 weeks. The arrow indicates a submolar band suggestive of junction DNA sequences. (B) DNA hybridization of nested-
PCR products amplified with primers BRP-2 and BK-RRLT-5. (C) Hybridization of HindIII-digested nested-PCR products. B5, B6, and B7 are control
reactions without template DNA. Positive controls were performed with Dunlop BKV DNA. N, PCR-positive nonneoplastic tissue; T2 and T3, PCR-
positive tumors; T1, T4, T5, and T6, Southern blot-positive tumors. Molecular weight markers are 7, 6, 5, 4, 3, 2, 1.6, 1, and 0.5 kb. The 7-kb band
is not shown in C. Expected size of PCR products (Dunlop strain) is 2.9 kb for undigested DNA and 1.9, 0.46, 0.42, and 0.1 kb for HindIII restriction
fragments. Positive control shows that the 0.46 and 0.42 bands were not resolved under the employed conditions. The 0.1-kb fragment ran out of
the gel.
chromosomes (data not shown). Digestion with BamHI DNA for 8 hr at 377 in a buffer containing 70 mM glycin-
NaOH, 30 mM MgCl2 , 8 mM b-mercaptoethanol, 0.1 mMand EcoRI, which cut once within the BKV late region
and are expected to yield two hybridization bands (5), EDTA, 0.5 mM ATP, pH 9.4] (Fig. 4C). Sequences comi-
grating with the track of linear DNA, and indicated as l1produced a single, high-molecular weight signal, consis-
tent with integration within viral late region in a position and l2 , were, as expected, hydrolyzed by the enzyme (Fig.
4D). This specimen also contained integrated se-close to the BamHI and EcoRI restriction sites (Figs. 4A
and 4B). Digestion with HindIII, NdeI, and BanII endonu- quences, as several restriction endonucleases yielded
submolar bands of aberrant size (Fig. 3A and data notcleases, which cut several times within the BKV genome,
produced bands of aberrant size indicative of cell–DNA shown). Signals suggestive of DNA integrations were
also detected after electrophoresis of undigested DNAjunction sequences plus restriction fragments consistent
with the maintenance of the early region, confirming that [‘‘i’’ in Figs. 4D and, also, 4E (see below)].
Further analysis showed that viral episomes consistedBKV DNA was integrated within the late genes (Figs. 4A
and 4B). of a population of supercoiled and relaxed monomer and
concatamers. Untreated DNA was UV-irradiated for 5 minThe second carcinoma (specimen 27) contained a pop-
ulation of circular and linear episomes, the latter proba- at analytical intensity with a Foto/prepI transilluminator
(Fotodyne, New Berlin, Wisconsin) after electrophoresisbly corresponding to products of DNA nicking (Figs. 4C
and 4D). Four spots, migrating slower than the linear in 0.5 (w/v) agarose gel, followed by perpendicular elec-
trophoresis. This treatment, which generates DNA nicksDNA track in two-dimensional electrophoresis, and indi-
cated as s1 , r1 , r2 , r3 , were resistant to incubation with (1), converted s1 into a molecule comigrating with r1 ,
while mobility of r1 , r2 , r3 was not affected (Fig. 4E). TheExonuclease V, which specifically removes linear DNA
(30) [2 units of enzyme (Toyobo, Osaka, Japan) per mg of latter forms were, therefore, identified as circular, relaxed
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FIG. 4. (A) Southern blot analysis of a bladder carcinoma containing one copy per cell of BKV DNA (specimen 17). The enzymes employed in
the analysis are indicated. HindIII, NdeI, and BanII generated fragments corresponding to the early region of either MM (arrows) or Dunlop
(arrowheads) strains. Aberrant signals suggestive of DNA junction sequences are identified by their low mobility. Molecular weight markers are
phage lambda HindIII DNA fragments. (B) Restriction map of BKV DNA. Viral regulatory region (RR), early region (ER), and late region (LR) (Dunlop
strain) are indicated. Closed boxes, large T coding sequences; open box, late region. Large T intron is represented by a thin line. In brackets are
DNA sequences missing in BKV MM strain. Restriction enzymes are: E, EcoRI; B, BamHI; H, HindIII; Bn, BanII; N, NdeI. Recognition sites are upward
for Dunlop strain and downward for MM strain. The size of the restriction fragments is indicated in kb. (C and D) 2D-electrophoresis of DNA from
a bladder carcinoma containing 50 copies per cell of BKV DNA (specimen 27). Linear forms are indicated by ‘‘l1’’ and ‘‘l2’’; circular forms by ‘‘s1’’, ‘‘r1’’,
‘‘r2’’, ‘‘r3’’; integrated sequences by ‘‘i’’. Lanes A and B are controls of the second dimension. (C) and lane A, DNA digested by Exonuclease V; (D)
and lane B, untreated DNA. Directions of first and second dimensions are pointed by ‘‘1r’’ and ‘‘2r’’. Phage lambda HindIII DNA fragments were
included in the first dimension as molecular weight standards. (E) UV treatment of specimen 27. The lane on the left is a control of nonirradiated
DNA. The expected position of ‘‘s1’’ is indicated by an arrowhead. A linear molecule generated by episome r2 is indicated by an asterisk. First
dimension was performed in recirculated TAE buffer containing 150 mM NaCl; under these conditions, integrated sequences (‘‘i’’) were better
resolved. Phage lambda HindIII DNA fragments were included in the first dimension as molecular weight standards. Circular form r3 was not
resolved in this experiment.
episomes and s1 as the supercoiled counterpart of r1 . In prototype genome. This pattern was shared by all the
episomes, as ascertained by digesting the DNA mole-addition, part of r2 was converted into a linear episome
comigrating with l2 . As the size of linear form l2 was cules by diffusion of the enzyme in the gel matrix after
electrophoresis of untreated DNA, followed by perpen-approximately twice that of l1 (Figs. 4D and 4E), l2-r2 most
likely represents the covalent dimer of l1 0 r1 . HindIII dicular electrophoresis (data not shown). Hence, viral
episomes consisted of a population of polymeric mole-digestion yielded bands of aberrant size and, among
them, a fragment of 6 kb, larger than the entire BKV cules based on a monomeric unit (l1 0 r1) of about 11–
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12 kb. A duplication probably involved part of the late was reported in other studies. One of these strains, TU,
was detected in the urine of immunosuppressed patientsregion, since an additional EcoRI site, splitting the mole-
cule roughly in half, was present (Fig. 3A). This specimen from Norway (27). Similarly to URO1, TU was present in
a large fraction of analyzed specimens (4/7, 57%) (11).did not show evidence of the replicative intermediates
typical of papovavirus runaway DNA replication. Inter- Another rearranged strain was rescued from several tu-
mor tissue biopsies after transfection of tumor DNA intotwined catenated dimers (26) were not detected, as uv
irradiation generated neither circular, nor linear mono- permissive cells. DNA sequences analysis showed that
all viral isolates had the same rearranged structure, withmers. Rolling-circle molecules, expected to migrate as a
smear from high molecular weight to monomeric DNA two duplications and a deletion in the BKV archetypal
enhancer (19, 21). These isolates were identical, by re-(4), were also absent, as the DNA smear observed in the
specimen was completely sensitive to Exonuclease V striction endonuclease analysis, to a new BKV strain
(BKV-IR) detected in, and subsequently isolated from, aand migrated with a mobility typical of linear DNA (Figs.
4C–4E). human insulinoma (6).
It was proposed that the natural, archetypal regulatoryViral rescue from this specimen was attempted by
transfecting total tumor DNA into W138 cells, permissive region of BKV consists of a linear array of functional
DNA elements, and that DNA rearrangements of BKVfor BKV infection. For 2 months the cell cultures were
observed for appearance of the typical BKV cytopathic regulatory region observed in laboratory strains are gen-
erated during the propagation of viral isolates in culturedeffect. At 2-week intervals the cultures were tested for
BKV hemoagglutination of human erythrocytes (22). After cells (20, 29). However, the identification of BKV-IR, TU,
and URO1 suggests that BKV regulatory region may often2 months the cells were analyzed by indirect immunofluo-
rescence for the presence of BKV VP antigens. Rescue undergo DNA rearrangements in vivo. These rearranged
variants may circulate in specific geographic areas, likeexperiments were repeated twice, but no cytopathic ef-
fect, hemoagglutinating activity, or immunofluorescence Italy and Norway. Alternatively, DNA rearrangements in
the viral regulatory region could be associated with BKVwere detected. These results suggest that the re-
arrangement of viral DNA was incompatible with run- latent infection. Prototype BKV, present in a minor fraction
of latently infected urothelial cells, might be preferentiallyaway DNA replication and productive infection. An alter-
native interpretation is that a functional large T antigen amplified and replicated under conditions of immune fail-
ure, explaining why archetype BKV DNA is frequentlywas not expressed in cultured cells. However, BKV DNA
replication and episomal maintenance requires large T amplified from urine of immunosuppressed patients.
These observations would deserve future investigation.antigen, suggesting that a functional large T was indeed
expressed in vivo. URO1 was present in both control and neoplastic tis-
sue specimens. Neoplastic and nonneoplastic tissuesIn the present study, BKV DNA was detected by PCR
in normal and diseased tissues from the prostate, kidney, were therefore associated with the same viral strain.
However, only neoplastic specimens contained viralureter, and bladder of Italian patients without apparent
immunological deficits. These organs, therefore, may be DNA in amounts detectable by Southern blot hybridiza-
tion. Unlike normal kidney parenchyma, which harborsunrecognized sites of BKV latent infection. A novel BKV
strain (URO1) was found to infect these patients. URO1 episomal latent BKV DNA (15), these neoplasms con-
tained rearranged and/or integrated sequences. The sizehas a 61-bp duplication of part of the 68- and 39-bp
elements present in the BKV archetypal enhancer, and of rearranged sequences was apparently incompatible
for assembly into a viral particle (12), and it was nota 68-bp deletion spanning part of the 39- and 63-bp en-
hancer elements. The identification of URO1 in nine of possible to detect molecular intermediates of papovavi-
rus DNA runaway replication in a bladder carcinoma con-nine specimens analyzed seems to reflect a true high
prevalence of this variant in the urinary tract of Italian taining episomal BKV DNA. Therefore, despite the fact
that urothelial cells are fully permissive to BKV, thesepatients rather than a laboratory artefact. URO1 was
characterized after amplification of viral DNA sequences Southern blot-positive tumors were not undergoing pro-
ductive infection. This finding suggests that BKV infectionby nested PCR, but negative-control PCR reactions pro-
cessed together with the specimens were always nega- may have different outcomes in normal urothelia and
neoplastic tissues. Other observations support the sug-tive. Three of these specimens were positive by Southern
blot hybridization, and it is therefore unlikely that a con- gestion that BKV may be associated with the pathogene-
sis of certain urinary tract tumors. The simple restrictiontamination masked the mass of endogenous viral DNA.
Finally, one of the Southern blot-positive specimens con- pattern of integrated and rearranged sequences indi-
cates that tumors were clonal and that DNA re-tained two point mutations; these mutations were not
found in the other samples, suggesting that cross-con- arrangement/integration occurred at an early stage of
neoplastic initiation or progression. A macroscopicallytaminations are unlikely under the experimental condi-
tions used in the study. A high prevalence of BKV strains intact full-length BKV early region, which encodes viral
transforming functions, was amplified from these speci-with DNA rearrangements in the viral regulatory region
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